The treatment of MGD involves heating the eyelids to improve meibomian gland function. 6 The main outcomes are improved symptoms, meibomian gland function, and tear film stability. 3 The ocular symptoms are typically burning, stinging, itching, irritation, light sensitivity and fluctuating blurred vision, 5 all of which could negatively impact quality of life and requires significant effort to manage. The clinical assessment of MGD involves quantifying symptoms, assessing the quality of meibum, examining the lid features and gland drop out, and examining tear film stability. In a recent report, MGD was recognized by the Osmoprotection in Dry Eye disease – Expert Opinion (OCEAN) group as six separate conditions primary obstructive keratinization of the meibomian gland, abnormal meibomian gland secretion, eyelid inflammation, corneal and conjunctival inflammation and epithelial damage, microbiological changes, and DED. It may result in alteration of the tear film, symptoms of eye irritation, clinically apparent inflammation, and ocular surface disease. … a chronic, diffuse abnormality of the meibomian glands, commonly characterized by terminal duct obstruction and/or qualitative/quantitative changes in the glandular secretion. Meibomian gland dysfunction (MGD) is the most common cause of dry eye disease 2 and is defined by The International Workshop on Meibomian Gland Dysfunction as This review summarized 58 human clinical studies and found that most eyelid warming devices were efficacious in improving signs and symptoms in a wide range of MGD severities and were generally safe to use.ĭefined by The Tear Film and Ocular Surface Dry Eye Workshop II (TFOS DEWS II),ĭry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles.
This narrative review was conducted to summarize the current state of knowledge on eyelid warming devices, specifically warm eye coverings, devices that direct heat and/or pressure to the eyelids, moisture chamber goggles, and light-based therapy. As a result, numerous medical devices have been developed and each have their own unique approach to treating MGD. Over the past two decades, there have been a surge of interest in diagnosing and managing MGD.
One of the mainstay therapies for MGD is medical devices that apply heat and/or pressure to the eyelids and promote the liquification and outflow of meibum into the tear film. This results in deficiencies in the tear film lipid layer which contributes to increased evaporation and destabilization of the tear film. You may rewarm the compress 3-6 times per day, following the above instructions.Meibomian gland dysfunction (MGD) is characterized by the obstruction and/or inflammation of the meibomian glands that result in decreased and altered meibum secretion.Inspect compress after use to ensure no damage has occurred to it then wash compress before storage.Once the compress is at the desired temperature, apply the covered compress gently to the eye area for 5-10 minutes.Do not excess 20 seconds in one interval. Add additional 5-second intervals in the microwave oven until desired temperature is reached.
If the compress is too hot, wait a few minutes and test again.
0 kommentar(er)
